A Neurotrophic Rationale for the Therapy of Neurodegenerative Disorders

Author(s): H. Uri Saragovi, Edith Hamel, Adriana Di Polo

Journal Name: Current Alzheimer Research

Volume 6 , Issue 5 , 2009

Become EABM
Become Reviewer


The concept and rationale for neuroprotection are presented. Several examples of small molecule neurotrophic agents with favourable drug-like and pharmacological properties are shown. Compound efficacy in acute neurodegenerative models (optic nerve axotomy) and chronic neurodegenerative models (glaucoma, age-associated cognitive impairment, Alzheimers Disease) are evaluated and discussed. Targeting neurotrophin receptors with ligands that activate survival pathways or inhibit death pathways is an alternative worth pursuing.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [419 - 423]
Pages: 5
DOI: 10.2174/156720509789207912
Price: $65

Article Metrics

PDF: 8